
Results
5
Companies which are potentially undervalued and in an acceptable financial position.
5 companies
Merck KGaA
Market Cap: €47.0b
Operates as a science and technology company in Europe, North America, Latin America, Middle East and Africa, and the Asia Pacific.
MRK
€110.90
7D
-0.09%
1Y
-17.9%
SCHOTT Pharma KGaA
Market Cap: €2.0b
Develops, manufactures, and sells drug containment solutions and delivery systems for injectable drugs for pharma, biotech, and life science industries worldwide.
1SXP
€13.58
7D
-2.2%
1Y
-45.9%
Bayer
Market Cap: €39.4b
Operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil.
BAYN
€40.21
7D
1.5%
1Y
62.4%
Evotec
Market Cap: €756.1m
Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.
EVT
€4.39
7D
-6.8%
1Y
-34.0%
Formycon
Market Cap: €341.3m
A biotechnology company, develops biosimilar drugs in Germany and Switzerland.
FYB
€19.84
7D
-1.8%
1Y
-25.6%